Mechanical inhibition of isolated Vo from V/A-ATPase for proton conductance

  1. Jun-ichi Kishikawa
  2. Atsuko Nakanishi
  3. Aya Furuta
  4. Takayuki Kato
  5. Keiichi Namba
  6. Masatada Tamakoshi
  7. Kaoru Mitsuoka
  8. Ken Yokoyama  Is a corresponding author
  1. Kyoto Sangyo University, Japan
  2. Osaka University, Japan
  3. Tokyo University of Pharmacy and Life Sciences, Japan

Abstract

V-ATPase is an energy converting enzyme, coupling ATP hydrolysis/synthesis in the hydrophilic V1 domain, with proton flow through the Vo membrane domain, via rotation of the central rotor complex relative to the surrounding stator apparatus. Upon dissociation from the V1 domain, the Vo domain of the eukaryotic V-ATPase can adopt a physiologically relevant auto-inhibited form in which proton conductance through the Vo domain is prevented, however the molecular mechanism of this inhibition is not fully understood. Using cryo-electron microscopy, we determined the structure of both the holo V/A-ATPase and isolated Vo at near-atomic resolution, respectively. These structures clarify how the isolated Vo domain adopts the auto-inhibited form and how the holo complex prevents formation of the inhibited Vo form.

Data availability

The density maps and the built models for Tth VoV1, Tth V1 (focused refined), and Tth Vo were deposited in EMDB (EMDB ID; 30013, 30014, and 30015) and PDB (PDB ID; 6LY8 for V1 and 6LY9 for isolated Vo), respectively. All data is available in the main text or the supplementary materials.

The following data sets were generated

Article and author information

Author details

  1. Jun-ichi Kishikawa

    Department of Molecular Biosciences, Kyoto Sangyo University, Kyoto, Japan
    Competing interests
    The authors declare that no competing interests exist.
  2. Atsuko Nakanishi

    Department of Molecular Biosciences, Kyoto Sangyo University, Kyoto, Japan
    Competing interests
    The authors declare that no competing interests exist.
  3. Aya Furuta

    Department of Molecular Biosciences, Kyoto Sangyo University, Kyoto, Japan
    Competing interests
    The authors declare that no competing interests exist.
  4. Takayuki Kato

    Institute for Protein Research, Osaka University, Osaka, Japan
    Competing interests
    The authors declare that no competing interests exist.
  5. Keiichi Namba

    Institute for Protein Research, Osaka University, Osaka, Japan
    Competing interests
    The authors declare that no competing interests exist.
  6. Masatada Tamakoshi

    Department of Molecular Biology, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan
    Competing interests
    The authors declare that no competing interests exist.
  7. Kaoru Mitsuoka

    Research Center for Ultra-High Voltage Electron Microscopy, Osaka University, Osaka, Japan
    Competing interests
    The authors declare that no competing interests exist.
  8. Ken Yokoyama

    Department of Molecular Biosciences, Kyoto Sangyo University, Kyoto, Japan
    For correspondence
    yokoken@cc.kyoto-su.ac.jp
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6813-1096

Funding

Japan Society for the Promotion of Science (17H03648)

  • Ken Yokoyama

Japan Agency for Medical Research and Development (JP17am0101001)

  • Kaoru Mitsuoka

Ministry of Education, Culture, Sports, Science, and Technology (12024046)

  • Kaoru Mitsuoka

Takeda Science Foundation

  • Ken Yokoyama

Japan Science and Technology Agency (JPMJCR1865)

  • Kaoru Mitsuoka

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Kishikawa et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,179
    views
  • 347
    downloads
  • 13
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jun-ichi Kishikawa
  2. Atsuko Nakanishi
  3. Aya Furuta
  4. Takayuki Kato
  5. Keiichi Namba
  6. Masatada Tamakoshi
  7. Kaoru Mitsuoka
  8. Ken Yokoyama
(2020)
Mechanical inhibition of isolated Vo from V/A-ATPase for proton conductance
eLife 9:e56862.
https://doi.org/10.7554/eLife.56862

Share this article

https://doi.org/10.7554/eLife.56862

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Angel D'Oliviera, Xuhang Dai ... Jeffrey S Mugridge
    Research Article

    The SARS-CoV-2 main protease (Mpro or Nsp5) is critical for production of viral proteins during infection and, like many viral proteases, also targets host proteins to subvert their cellular functions. Here, we show that the human tRNA methyltransferase TRMT1 is recognized and cleaved by SARS-CoV-2 Mpro. TRMT1 installs the N2,N2-dimethylguanosine (m2,2G) modification on mammalian tRNAs, which promotes cellular protein synthesis and redox homeostasis. We find that Mpro can cleave endogenous TRMT1 in human cell lysate, resulting in removal of the TRMT1 zinc finger domain. Evolutionary analysis shows the TRMT1 cleavage site is highly conserved in mammals, except in Muroidea, where TRMT1 is likely resistant to cleavage. TRMT1 proteolysis results in reduced tRNA binding and elimination of tRNA methyltransferase activity. We also determined the structure of an Mpro-TRMT1 peptide complex that shows how TRMT1 engages the Mpro active site in an uncommon substrate binding conformation. Finally, enzymology and molecular dynamics simulations indicate that kinetic discrimination occurs during a later step of Mpro-mediated proteolysis following substrate binding. Together, these data provide new insights into substrate recognition by SARS-CoV-2 Mpro that could help guide future antiviral therapeutic development and show how proteolysis of TRMT1 during SARS-CoV-2 infection impairs both TRMT1 tRNA binding and tRNA modification activity to disrupt host translation and potentially impact COVID-19 pathogenesis or phenotypes.

    1. Developmental Biology
    2. Structural Biology and Molecular Biophysics
    Elise S Bruguera, Jacob P Mahoney, William I Weis
    Research Article

    Wnt/β-catenin signaling directs animal development and tissue renewal in a tightly controlled, cell- and tissue-specific manner. In the mammalian central nervous system, the atypical ligand Norrin controls angiogenesis and maintenance of the blood-brain barrier and blood-retina barrier through the Wnt/β-catenin pathway. Like Wnt, Norrin activates signaling by binding and heterodimerizing the receptors Frizzled (Fzd) and low-density lipoprotein receptor-related protein 5 or 6 (LRP5/6), leading to membrane recruitment of the intracellular transducer Dishevelled (Dvl) and ultimately stabilizing the transcriptional coactivator β-catenin. Unlike Wnt, the cystine knot ligand Norrin only signals through Fzd4 and additionally requires the co-receptor Tetraspanin12 (Tspan12); however, the mechanism underlying Tspan12-mediated signal enhancement is unclear. It has been proposed that Tspan12 integrates into the Norrin-Fzd4 complex to enhance Norrin-Fzd4 affinity or otherwise allosterically modulate Fzd4 signaling. Here, we measure direct, high-affinity binding between purified Norrin and Tspan12 in a lipid environment and use AlphaFold models to interrogate this interaction interface. We find that Tspan12 and Fzd4 can simultaneously bind Norrin and that a pre-formed Tspan12/Fzd4 heterodimer, as well as cells co-expressing Tspan12 and Fzd4, more efficiently capture low concentrations of Norrin than Fzd4 alone. We also show that Tspan12 competes with both heparan sulfate proteoglycans and LRP6 for Norrin binding and that Tspan12 does not impact Fzd4-Dvl affinity in the presence or absence of Norrin. Our findings suggest that Tspan12 does not allosterically enhance Fzd4 binding to Norrin or Dvl, but instead functions to directly capture Norrin upstream of signaling.